Changes in lipid-lowering therapy following a cardiovascular event in patients with diabetes

被引：0
|
作者：
Okerson, T. [1 ]
Cohen, S. S. [2 ]
Killian, J. M. [3 ]
Weston, S. A. [3 ]
Monda, K. L. [1 ]
Chamberlain, A. M. [3 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA USA
[2] EpidStat Inst, Ann Arbor, MI USA
[3] Mayo Clin, Rochester, MN USA
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1167
引用
收藏
页码：S537 / S538
页数：2
相关论文
共 50 条
  • [1] Changes in lipid-lowering therapy prescription patterns following a second cardiovascular disease event
    Chamberlain, A.
    Cohen, S.
    Killian, J.
    Weston, S.
    Okerson, T.
    Monda, K.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 31 - 31
  • [2] Comparison of Lipid-Lowering Treatment in Patients with Diabetes and/or Cardiovascular Disease
    Cohen, Sarah S.
    Chamberlain, Alanna M.
    Killian, Jill M.
    Monda, Keri L.
    Weston, Susan A.
    Okerson, Ted
    [J]. DIABETES, 2017, 66 : LB57 - LB57
  • [3] Lipid-lowering therapy in diabetes mellitus
    Niemeijer-Kanters, SDJM
    Banga, JD
    Erkelens, DW
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2001, 58 (05): : 214 - 222
  • [4] Combination lipid-lowering therapy in diabetes
    Michael H. Davidson
    [J]. Current Diabetes Reports, 2003, 3 (3) : 263 - 268
  • [5] LIPID-LOWERING THERAPY AFTER AN ATHEROSCLEROTIC EVENT
    ROBERTS, WC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (10): : 693 - 695
  • [6] Cardiovascular risk and lipid-lowering drug therapy
    Stulnig, T.
    [J]. DIABETOLOGE, 2012, 8 (07): : 568 - 572
  • [7] Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease
    Chamberlain, Alanna M.
    Cohen, Sarah S.
    Killian, Jill M.
    Monda, Ken L.
    Weston, Susan A.
    Okerson, Ted
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (07): : 995 - 1001
  • [8] Lipids, lipid-lowering therapy and diabetes complications
    Valensi, P.
    Picard, S.
    [J]. DIABETES & METABOLISM, 2011, 37 (01) : 15 - 24
  • [9] Lipid-lowering Therapy in Patients With High Cardiovascular Risk: Dose or Combination?
    Roever, Leonardo
    Biondi-Zoccai, Giuseppe
    Rao, Sunil V.
    [J]. CLINICAL THERAPEUTICS, 2017, 39 (03) : 659 - 660
  • [10] Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus
    Betteridge, J
    [J]. AMERICAN JOURNAL OF MEDICINE, 2005, 118 : 10S - 15S
12345